News & Insights

Discover the latest updates on our company and investments in life science

Sciety news

Major investment interest in award-wining 1928 Diagnostics

Ett trettiotal affärsänglar går in med 20 miljoner kronor i diagnostikbolaget som med sin innovativa mjukvara ska bekämpa det globala hotet från antibiotikaresistens. Investeringarna sker via Sciety som är specialiserat på tillväxtbolag inom hälsa och medicin. Med 1928 Diagnostics mjukvara kan man med hjälp av teknik som redan finns på

Read More »

Sciety is a capital partner specialising in life science and healthcare, offering services in capital raising and related areas. Sciety may currently have, may previously have had or may in the future be engaged by companies mentioned in our communications or operating in the sectors described, and may hold ownership interests in such companies. Sciety receives remuneration for its services, including commissions in connection to capital raises. Our communication is intended for informational purposes only and does not constitute personal investment advice. We do not guarantee the accuracy, completeness or timeliness of the information provided. Investment decisions should not be based solely on this communication.